On Wednesday, June 28, 2023, Morrison Foerster partner Brigid Bondoc is a panelist on “It’s a Matter of Interpretation: What Can the Industry Glean About the Future of Dietary Supplement Regulation Based on Recent FDA Activity,” at ACI’s 11thAnnual Legal, Regulatory and Compliance Forum on Dietary Supplements in New York, NY. The panel will discuss the following topics:
Assessing how the FDA’s reorganization of the Human Foods Program will impact the future of dietary supplements and functional foods
Examining FDA’s recent Final Guidance on Best Practices for Convening a GRAS Panel and how this affects the industry
Lessons and takeaways from the latest trends in FDA enforcement and warning letters
What assumptions can we make about when FDA will release an updated NDI guidance and what will that guidance include?